A. Deveney

发表

Dopamine receptor multiplicity: "D1-like'-"D2-like' interactions and " D1-like" receptors not linked to adenylate cyclase.

J. Waddington, A. Deveney, 1996, Biochemical Society transactions.

Evidence for dopamine 'D1-like' receptor subtypes in the behavioural effects of two new selective antagonists, LY 270411 and BW 737C.

J. Waddington, A. Deveney, 1996, European journal of pharmacology.

Behavioral analysis of multiple D1-like dopamine receptor subtypes: new agents and studies in transgenic mice with D1A receptor knockout.

D. Sibley, J. Waddington, J. Drago, 1998, Advances in pharmacology.

National Scientific Medical Meeting 1994 Abstracts

P. W. Johnston, David J Brayden, D. Noone, 1994 .

Comparison of the new atypical antipsychotics olanzapine and ICI 204,636 with clozapine on behavioural responses to the selective “D1-like” dopamine receptor agonist A 68930 and selective “D2-like” agonist RU 24213

J. Waddington, A. Deveney, 1996, Psychopharmacology.

Population Pharmacokinetic Meta-Analysis to Bridge Ferumoxytol Plasma Pharmacokinetics Across Populations

N. Wood, A. Facius, G. Lahu, 2014, Clinical Pharmacokinetics.

Behavioural pharmacology op ‘D-1-like’ dopamine receptors: Further subtyping, new pharmacological probes and interactions with ‘D-2-like’ receptors

S. A. Daly, J. Waddington, K. O’boyle, 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

A pharmacological validation of radiotelemetry in conscious, freely moving rats.

D. Jackson, A. Kjellström, T. Forsberg, 1998, Journal of pharmacological and toxicological methods.

Psychopharmacological Distinction Between Novel Full-Efficacy “D1-like” Dopamine Receptor Agonists

J. Waddington, A. Deveney, 1997, Pharmacology Biochemistry and Behavior.

Two selective 5-HT1A receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatised to their environment and alter their behaviour: a behavioural analysis

D. Jackson, E. Jerning, A. Deveney, 1998, Psychopharmacology.

The neuronal selective nitric oxide inhibitor AR-R 17477, blocks some effects of phencyclidine, while having no observable behavioural effects when given alone.

D. Jackson, D. Reif, A. Deveney, 1999, Pharmacology & toxicology.

Forest Carbon Index: the geography of forests in climate solutions

M. Obersteiner, M. Gusti, G. Kindermann, 2009 .

The nitric oxide synthase inhibitor. L-NAME, blocks certain phencyclidine-induced but not amphetamine-induced effects on behaviour and brain biochemistry in the rat

Jörgen A. Engel, D. Jackson, C. Johansson, 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Pharmacological characterization of behavioural responses to SK&F 83959 in relation to ‘D1‐like’ dopamine receptors not linked to adenylyl cyclase

J. Waddington, A. Deveney, Aaron M. Deveney, 1995, British journal of pharmacology.